GPM #:
Keyword:


# GPM # proteins Description
1. GPM77710000270
peptide
model
gel
aaa
go
mh 		44
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2445 for details associated with this sample.
2. GPM77710000271
peptide
model
gel
aaa
go
mh 		29
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2446 for details associated with this sample.
3. GPM77710000272
peptide
model
gel
aaa
go
mh 		3
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2447 for details associated with this sample.
4. GPM77710000273
peptide
model
gel
aaa
go
mh 		6
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2448 for details associated with this sample.
5. GPM77710000274
peptide
model
gel
aaa
go
mh 		5
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2449 for details associated with this sample.
6. GPM77710000275
peptide
model
gel
aaa
go
mh 		58
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2450 for details associated with this sample.
7. GPM77710000276
peptide
model
gel
aaa
go
mh 		13
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2451 for details associated with this sample.
8. GPM77710000277
peptide
model
gel
aaa
go
mh 		22
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2452 for details associated with this sample.
9. GPM77710000278
peptide
model
gel
aaa
go
mh 		7
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2453 for details associated with this sample.
10. GPM77710000279
peptide
model
gel
aaa
go
mh 		7
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2454 for details associated with this sample.
11. GPM77710000280
peptide
model
gel
aaa
go
mh 		23
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2455 for details associated with this sample.
12. GPM77710000281
peptide
model
gel
aaa
go
mh 		7
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2456 for details associated with this sample.
13. GPM77710000282
peptide
model
gel
aaa
go
mh 		7
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2457 for details associated with this sample.
14. GPM77710000283
peptide
model
gel
aaa
go
mh 		5
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2458 for details associated with this sample.
15. GPM77710000284
peptide
model
gel
aaa
go
mh 		54
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2459 for details associated with this sample.
16. GPM77710000285
peptide
model
gel
aaa
go
mh 		20
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2460 for details associated with this sample.
17. GPM77710000286
peptide
model
gel
aaa
go
mh 		22
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2461 for details associated with this sample.
18. GPM77710000287
peptide
model
gel
aaa
go
mh 		9
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2462 for details associated with this sample.
19. GPM77710000288
peptide
model
gel
aaa
go
mh 		45
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2463 for details associated with this sample.
20. GPM77710000289
peptide
model
gel
aaa
go
mh 		9
  1. BRENDA cell culture: none
  2. BRENDA tissue: none
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: bernhard.kuster@cellzome.com
  6. institution: Cellzome AG, Meyerhofstrasse 1, 69117 Heidelberg
  7. name: Bantscheff M, et al.
  8. project: Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
  9. project comment: Nat Biotechnol. 2007 Sep;25(9):1035-44 (PubMed). See PRIDE 2464 for details associated with this sample.

Page 1 of 37 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | >> | 37 |
Key word(s): 17721511
Total protein ids = 201012
If you do not see a red dot in the square brackets [], you will need Adobe's SVG plugin to view this site properly.













dblist_gpmnotes.pl, v. 2010.07.06